Search
for
Sort by
Research 91–120 of 326
- Post-finasteride syndrome – does it really exist?
- Purple corn extract improves benign prostatic hyperplasia by inhibiting 5 alpha-reductase type 2 and inflammation in testosterone propionate-induced rats
- Synergistic Trichogenic Efficacy of Wedelia chinensis and Cassytha filiformis Emulgel in Murine Models
- Precision-Based Management of Chronic Hair Fall: A Genomic-Guided Trichology Approach - A Case Analysis from Qatar
- Finasteride en el año 2006
- 5α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopecia
- Polycystic ovary syndrome
- Cutaneous Androgen Metabolism: Basic Research and Clinical Perspectives
- The 5 Alpha-Reductase Isozyme Family: A Review of Basic Biology and Their Role in Human Diseases
- Androgenetic alopecia: pathogenesis and potential for therapy
- Androgen Signaling Regulates SARS-CoV-2 Receptor Levels and Is Associated with Severe COVID-19 Symptoms in Men
- Advances in Regenerative Stem Cell Therapy in Androgenic Alopecia and Hair Loss: Wnt Pathway, Growth-Factor, and Mesenchymal Stem Cell Signaling Impact Analysis on Cell Growth and Hair Follicle Development
- Structure of human type II 5 alpha-reductase gene.
- Diagnosis of hyperandrogenism: Biochemical criteria
- Review of Hair Follicle Dermal Papilla cells as <i>in vitro</i> screening model for hair growth
- The E211 G>A Androgen Receptor Polymorphism Is Associated with a Decreased Risk of Metastatic Prostate Cancer and Androgenetic Alopecia
- Effects of 5-alpha reductase inhibitors on erectile function, sexual desire and ejaculation
- Advanced nanocarrier- and microneedle-based transdermal drug delivery strategies for skin diseases treatment
- Finasteride Inhibits Human Prostate Cancer Cell Invasion through MMP2 and MMP9 Downregulation
- Delivery of Tissue-Targeted Scalpels: Opportunities and Challenges for <i>In Vivo</i> CRISPR/Cas-Based Genome Editing
- Relationships between cerebrospinal fluid GABAergic neurosteroid levels and symptom severity in men with PTSD
- GWAS for male-pattern baldness identifies 71 susceptibility loci explaining 38% of the risk
- Female Pattern Hair Loss
- 46,XY DSD due to impaired androgen production
- Regulation of masculinization: androgen signalling for external genitalia development
- Male pattern baldness: current treatments, future prospects
- 5-Alpha reductase deficiency
- Assessment of the usefulness of dihydrotestosterone in the diagnostics of patients with androgenetic alopecia
- In silico prediction of prostaglandin D2 synthase inhibitors from herbal constituents for the treatment of hair loss
- The Basic Science of Hair Biology